RPL3P9

Across TCGA pan-cancer cohorts, RPL3P9 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL3P9 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL3P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL3P9 expression acts as an unfavorable survival marker, although some lineages such as KIRC and COAD show a favorable association.

ACC, KIRC, and COAD are the cancer types where RPL3P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.232	0.652	<.001	59	view →
KIRC	OS	Tertile	All	0.710	0.539	.002	46	view →
COAD	OS	Median	All	0.853	0.747	.003	46	view →
LUSC	OS	Tertile	II,III,IV	0.508	0.281	.005	30	view →
LGG	OS	Tertile	All	0.942	0.826	<.001	29	view →
MESO	DFS	Tertile	II,III,IV	0.612	0.129	.001	27	view →
BRCA	OS	Tertile	All	0.649	0.478	.004	17	view →
STAD	DFS	Quartile	III,IV	0.407	0.699	.007	17	view →
THCA	DFS	Quartile	IV	1.000	0.427	.002	15	view →
BLCA	DFS	Tertile	IV	0.405	0.627	.023	12	view →
CESC	OS	Quartile	IV	0.258	0.704	.029	12	view →
THYM	DFS	Tertile	All	1.000	0.454	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPL3P9–ACC (DFS)

Open the ACC breakdown →